Evidence map›Paper›PMID 35700153›Full record

ArticleThe British journal of dermatology2022

Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system.

Bethany Cucka, Bianca Biglione, Li Zhou, Elizabeth J Phillips, Fatima Bassir, Upeka Samarakoon, Renajd Rrapi, Sidharth Chand, Liqin Wang, Santiago Alvarez-Arango and 2 more

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Bethany CuckaDepartment of Dermatology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1163-7272
Bianca BiglioneDepartment of Dermatology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0003-3779-4388
Li ZhouDivision of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Elizabeth J PhillipsCenter for Drug Safety and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Fatima BassirDivision of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Upeka SamarakoonDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Renajd RrapiDepartment of Dermatology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-9795-2865
Sidharth ChandDepartment of Dermatology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-5725-6600
Liqin WangDivision of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Santiago Alvarez-ArangoDivision of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kimberly G BlumenthalDivision of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Daniela KroshinskyDepartment of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
Massachusetts General Hospital · USBrigham and Women's Hospital · USJohns Hopkins University · USVanderbilt University Medical Center · US

Funding

Clinical Pharmacology Training ProgramT32GM066691 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Matthew Michael Ippolito · 2003 to 2026
$6.4M
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug ReactionsR01AI150295 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHOU, LI · 2019 to 2022
$2.8M
NIAID NIH HHS R01 AI150295NIGMS NIH HHS T32 GM066691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Drug Hypersensitivity SyndromeEosinophiliaDelivery of Health CareHumans

Identifiers

PMID35700153
PMCPMC9350236
OpenAlexW4282821928

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.